Lower medication prices buy more years of life for the elderly

March 26, 2002

Policies that encourage lower drug costs could result in longer lives for many elderly patients who are dependent on these medications, according to a new study.

"A Medicare drug benefit program that supports prices at the high end of the current range could yield substantially less health for the elderly," say Louise B. Russell, Ph.D., and Nancy Wolff, Ph.D., of Rutgers University, writing in the current issue of the American Journal of Preventive Medicine.

Russell and Wolff reviewed the results of studies that had examined the costs and health effects of using medications in the elderly. The five studies were published between 1990 and 2000 and all data were adjusted to the value of the dollar in 2000.

Based on these studies, Russell and Wolff estimated how many years of life would be added for every $1 million spent if the medications were sold at the average wholesale price (AWP), 20 percent below the AWP and 40 percent below the AWP.

Federal purchasers pay approximately 40 percent to 50 percent less than the AWP. Managed care plans typically pay more than do federal purchasers, and individuals without prescription drug insurance usually pay the highest prices.

Three of the reviewed studies investigated the use of a group of drugs called statins, which reduce cholesterol levels.

Using the results of these studies, Russell and Wolff estimated that, in elderly patients with a history of myocardial infarction, reducing the cost of these drugs by 40 percent nearly doubles the extension of life statins are capable of producing.

At 40 percent below the AWP, every $1 million buys enough statins to extend by 90 years collectively the lives of the U.S. population of heart patients between the ages of 75 and 84 years. This dropped to 63 years of life when the medications were priced at 20 percent below the AWP and was only 48 years at the AWP.

America spent $8.2 billion on cholesterol-lowering drugs in 2000, according to a report from the National Institute for Health Care Management Research and Educational Foundation.

"Much of the discussion regarding the addition of a prescription drug benefit to Medicare has centered on issues of cost -- budgetary cost to Medicare and out-of-pocket costs to the elderly. Important and easily measured, costs have overshadowed the health consequences of the benefit," say Russell and Wolff.

Instead, they suggest that "it is important to evaluate drug benefit proposals in terms of health effects per dollar, not just dollars."

Russell and Wolff conducted the study as faculty members of Rutger's Institute for Health, Health Care Policy and Aging Research.
The American Journal of Preventive Medicine, sponsored by the Association of Teachers of Preventive Medicine and the American College of Preventive Medicine, is published eight times a year by Elsevier Science. The Journal is a forum for the communication of information, knowledge and wisdom in prevention science, education, practice and policy. For more information about the Journal, contact the editorial office at (619) 594-7344.

Center for Advancing Health

Related Statins Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Twitter data research reveals more about what patients think about statins
More than one in seven people taking statins -- prescribed to lower cholesterol levels -- believed that meant they could still eat unhealthy foods, a new study shows.

Statins starve cancer cells to death
More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels.

Statins linked to higher diabetes risk
Individuals who take cholesterol-lowering statins may be at higher risk for developing high blood sugar levels, insulin resistance, and eventually type 2 diabetes, according to an analysis published in the British Journal of Clinical Pharmacology.

Statins could protect against motor neurone disease
High cholesterol has been found to be a possible risk factor for the development of motor neurone disease (MND), according to a large study of genetic data led in the UK by Queen Mary University of London, in collaboration with the National Institutes of Health in the USA.

Statins are more effective for those who follow the Mediterranean diet
For those who have already had a heart attack or a stroke, the combination of statins and Mediterranean Diet appears to be the most effective choice to reduce the risk of mortality, especially from cardiovascular causes.

Statins have low risk of side effects
Cholesterol-lowering statin drugs are associated with a low risk of side effects.

Statins overprescribed for primary prevention
Taking cholesterol-lowering drugs, or statins, as a preventive measure can reduce the risk of cardiovascular disease.

Many older adults do not take prescribed statins properly
In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

Statins show little promise for conditions other than heart disease
Medicines commonly prescribed to reduce people's risk of heart attack may have limited use for treating other diseases, research suggests.

Read More: Statins News and Statins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.